Idiopathic nonhistaminergic angioedema

Area of Science:

• Immunology
• Allergy
• Genetics

Background:

• Idiopathic nonurticarial angioedema presents a diagnostic challenge, particularly when unresponsive to standard antihistamine treatments.
• Understanding the characteristics and treatment responses of this condition is crucial for effective patient management.

Purpose of the Study:

• To characterize patients with idiopathic nonhistaminergic angioedema.
• To evaluate the efficacy of prophylactic tranexamic acid treatment in this patient group.

Main Methods:

• A cohort of 25 patients with idiopathic nonurticarial angioedema, unresponsive to H1 blockers, was identified.
• Patients underwent exclusion of other angioedema causes via clinical assessment and diagnostic tests.
• Tranexamic acid was administered prophylactically to 15 patients with severe symptoms.

Main Results:

• The study identified 25 patients with idiopathic nonhistaminergic angioedema, with symptom onset typically in adulthood.
• A significant proportion experienced frequent attacks affecting skin, pharynx/larynx, and gastrointestinal tract.
• Prophylactic tranexamic acid significantly reduced attack frequency in 11 patients and provided partial remission in 4 others.

Conclusions:

• Idiopathic nonhistaminergic angioedema shares clinical features and treatment responses with C1 inhibitor deficiency.
• These similarities suggest a potential common underlying pathogenesis, possibly involving the bradykinin pathway.
• Tranexamic acid demonstrates therapeutic potential for idiopathic nonhistaminergic angioedema, supporting its use in select cases.